| Literature DB >> 23956969 |
Bikash Ranjan Sahoo1, Madhubanti Basu, Banikalyan Swain, Manas Ranjan Dikhit, Pallipuram Jayasankar, Mrinal Samanta.
Abstract
Toll-like receptors (TLRs) play key roles in sensing wide array of microbial signatures and induction of innate immunity. TLR2 in fish resembles higher eukaryotes by sensing peptidoglycan (PGN) and lipoteichoic acid (LTA) of bacterial cell wall and zymosan of yeasts. However, in fish TLR2, no study yet describes the ligand binding motifs in the leucine rich repeat regions (LRRs) of the extracellular domain (ECD) and important amino acids in TLR2-TIR (toll/interleukin-1 receptor) domain that could be engaged in transmitting downstream signaling. We predicted these in a commercially important freshwater fish species rohu (Labeo rohita) by constructing 3D models of TLR2-ECD, TLR2-TIR, and MyD88-TIR by comparative modeling followed by 40 ns (nanosecond) molecular dynamics simulation (MDS) for TLR2-ECD and 20 ns MDS for TLR2-TIR and MyD88-TIR. Protein (TLR2-ECD)-ligands (PGN, LTA, and zymosan) docking in rohu by AutoDock4.0, FlexX2.1, and GOLD4.1 anticipated LRR16-19, LRR12-14, and LRR20-CT as the most important ligand binding motifs. Protein (TLR2-TIR)-protein (MyD88-TIR) interaction by HADDOCK and ZDOCK predicted BB loop, α B-helix, α C-helix, and CD loop in TLR2-TIR and BB loop, α B-helix, and CD loop in MyD88-TIR as the critical binding domains. This study provides ligands recognition and downstream signaling.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23956969 PMCID: PMC3727187 DOI: 10.1155/2013/185282
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Multiple sequence alignment and secondary structure prediction of TLR2-TIR domain. (a) Multiple sequence alignment of TLR2-TIR domain of rohu with others by MegAlign program. Conserved residues were shown in yellow. Consensus residues are shown in the majority axis. (b) Secondary structure representation of TLR2-TIR domain by PSIPRED. Helices denoted as “H,” beta strands as “E,” and loops as “C.”
Figure 2Multiple sequence alignment and secondary structure prediction of MyD88-TIR domain. (a) Multiple sequence alignment of MyD88-TIR domain of common carp with others by MegAlign program. Conserved residues were shown in yellow. Consensus residues are shown in the majority axis. (b) Secondary structure representation of MyD88-TIR domain by PSIPRED. Helices denoted as “H,” beta strands as “E,” and loops as “C.”
Sequence identities between rohu TLR2-ECD (target) and mouse TLR2-ECD (template).
| LRR | Identity (%) | LRR | Identity (%) |
|---|---|---|---|
| 1 | 47.82 | 12 | 27.77 |
| 2 | 29.16 | 13 | 20 |
| 3 | 63.63 | 14 | 33.33 |
| 4 | 52 | 15 | 37.93 |
| 5 | 34.46 | 16 | 34.78 |
| 6 | 35.57 | 17 | 50 |
| 7 | 9.52 | 18 | 52.38 |
| 8 | 15.38 | 19 | 50 |
| 9 | 28.57 | 20 | 40.9 |
| 10 | 26.31 | 21 | 29.16 |
| 11 | 28 |
Sequence identities between rohu TLR2-TIR (target) and human TLR2-TIR (template).
| Position | Identity (%) | Position | Identity (%) |
|---|---|---|---|
|
| 100 | CD loop | 46.66 |
| AA loop | 66.67 |
| 60 |
|
| 58.33 | DD loop | 69.23 |
|
| 42.85 |
| 88.88 |
| BB Loop | 100 | DE loop | 50 |
|
| 90.9 |
| 100 |
|
| 75 | EE loop | 50 |
|
| 69.23 |
| 50 |
Sequence identities between common carp MyD88-TIR (target) and human MyD88-TIR (template).
| Position | Identity (%) | Position | Identity (%) |
|---|---|---|---|
|
| 100 | CC loop | 66.66 |
| AA loop | 80 |
| 60 |
|
| 69.23 | DD loop | 70.58 |
|
| 100 |
| 100 |
| BB Loop | 86.66 | EE loop | 66.66 |
|
| 100 |
| 68.75 |
|
| 85.71 |
Figure 3Root mean square deviation (RMSD) analysis. RMSD of (a) TLR2-ECD up to 40 ns and (b) MyD88-TIR and TLR2-TIR domains up to 20 ns MD simulation.
Figure 4Root mean square fluctuation (RMSF) analysis for homology models. RMSF per residue over the dynamics was shown in graph. (a) TLR2-ECD; (b) TLR2-TIR; (c) MyD88-TIR.
Figure 5Illustration of the interaction of PGN, LTA, and zymosan with the modeled 3D structure of rohu TLR2-ECD by AutoDock 4.0 program. At B5 region, interaction of PGN-I with TLR2-ECD (a) and PGN-DAP with TLR2-ECD (b); at B6 region, interaction of PGN-I with TLR2-ECD (c) and PGN-DAP with TLR2-ECD (d); interaction of LTA with TLR2-ECD (e) and zymosan with TLR2-ECD (f). The TLR2-ECD was shown in ribbon and ligands (PGN, LTA, and zymosan) were shown in solid form. Amino acid number depicted in the figure was shown as per the matured protein (after removal of the signal peptide).
Figure 6Illustration of the interaction of PGN, LTA, and zymosan with the modeled 3D structure of rohu TLR2-ECD by GOLD 4.1 program. Interaction of (a) PGN-I and TLR2-ECD at LRR16-19; (b) PGN-II and TLR2-ECD at LRR16-19; (c) PGN-DAP and TLR2-ECD at LRR16-19; (d) PGN-II and TLR2-ECD at LRR8-10; (e) zymosan and TLR2-ECD at LRR20-CT; (f) LTA and TLR2-ECD at LRR12-14. Rohu TLR2-ECD model was shown as line and ligands (PGN, LTA, and zymosan) are shown as stick.
Figure 7Interaction of TLR2-TIR and MyD88-TIR in Discovery Studio 2.5. (a) TLR2-TIR model is labeled as chain “A” and MyD88-TIR model is labeled as chain “B.” Interface residues are shown inside a rectangle box in ball and stick representation. (b) Clustering of interface residues between TLR2-TIR and MyD88-TIR domain in tree format. Residues of TLR2-TIR are marked as chain “A” and MyD88-TIR as chain “B.” Strongly interacting residues are highlighted with different colors.
List of hydrogen bond forming and hydrophobic interacting residues between TLR2-TIR and MyD88-TIR domains.
| Hydrogen bonds | Hydrophobic interactions | |||
|---|---|---|---|---|
| Donor | Acceptor | Length (Å) | Donor | Acceptor |
| Trp689-NE1 | Leu84-O | 1.97 | Ala73 | Gln654 |
| Ser715-O | Ser50-N | 2.34 | Gln77 | His655 |
| Ser715-O | Ile48-O | 2.84 | Tyr8 | Asp656 |
| Ser715-OG | Asp36-OD2 | 2.78 | Ser71 | His680 |
| Asp723-OD2 | Lys55-NZ | 2.70 | Asp72 | Lys681 |
| Thr714-N | Asp36-OD2 | 2.62 | Cys9 | Arg682 |
| Thr714-O | Asp36-O | 2.72 | Phe76 | Phe684 |
| Ser83-OG | Gly687-N | 2.94 | Lys79 | Pro686 |
| Gln654-NE2 | Asp38-OD2 | 2.72 | Leu82 | Gly687 |
| Ser11-SG | Asp656-OD1 | 3.15 | Ser83 | Trp689 |
| Cys9-NZ | Asp656-OD1 | 2.70 | Phe80 | Ile690 |
| Asp72-N | Asp656-OD2 | 2.56 | Leu84 | Glu710 |
| Cys9-NZ | His655-O | 2.61 | Cys85 | His711 |
| Cys9-NZ | His655-ND1 | 2.78 | Pro86 | Val713 |
| Pro686-O | Ser50-OG | 2.14 | Asp36 | Thr714 |
| Arg688-NH2 | Glu51-OE2 | 2.75 | Ala73 | Gln654 |
| Asp692-OD1 | Lys10-NZ | 2.20 | Gln77 | His655 |
| Lys681-NZ | Asp72-OD2 | 2.73 | Tyr8 | Asp656 |
| His655-NE2 | Asp75-OD2 | 1.91 | Ser71 | His680 |
Figure 8Hydrogen bond analysis of protein-ligand complexes. H-bond analysis of (a) PGN-I and TLR2-ECD complex, (b) PGN-II and TLR2-ECD complex, (c) PGN-DAP and TLR2-ECD complex, (d) PGN-II and TLR2-ECD complex at LRR8-10 region (B6), (e) LTA and TLR2-ECD complex at LRR20-CT, (f) and zymosan and TLR2-ECD complex at LRR12-14. X-axis represents time period of simulation and Y-axis represents number of hydrogen bonds.
(a) Validation by SAVES server
| Ramachandran plot (PROCHECK) | TLR2-ECD | TLR2-TIR | MyD88-TIR |
|---|---|---|---|
| Residue (%) | Residue (%) | Residue (%) | |
| Most favored regions | 66.7 | 78.7 | 73.2 |
| Additionally allowed regions | 30.0 | 20.6 | 24.4 |
| Generously allowed regions | 1.8 | 0.0 | 1.6 |
| Disallowed regions | 1.6 | 0.7 | 0.8 |
| Verify3D score | 95.37 | 97.28 | 87.6 |
| ERRAT | 61.059 | 86.364 | 86.325 |
| PROVE (mean | 1.609 | 1.48 | 1.63 |
(b) Stereochemical quality of homology models by ProQ, ModFOLD, and MetaMQAP server
| TLR2-ECD | TLR2-TIR | MyD88-TIR | |
|---|---|---|---|
| ProQ (LG/MX) | 7.062/0.432 | 6.401/0.772 | 7.067/0.847 |
| ModFOLD (Q/P) | 0.6326/0.0065 | 0.7473/0.00038 | 0.5787/0.0022 |
| MetaMQAP (GDT/RMSD) | 68.93/2.137 | 78.767/1.523 | 72.628/2.319 |
*ProQ-LG: >1.5 fairly good; >2.5 very good; >4 extremely good. ProQ-MX: >0.1 fairly good; >0.5 very good; >0.8 extremely good. ModFOLD-Q: >0.5 medium confidence; >0.75 high confidence. ModFOLD-P: <0.05 medium confidence; <0.01 high confidence. MetaMQAP-GDT/RMSD: an ideal model has a GDT score over 59 and an RMSD around 2.0 Å.
(a) Docking analysis of TLR2-ECD with PGN, LTA, and zymosan by AutoDock 4.0
| Grid centre and ligand | Interacting residues | Binding energy kcal/mol | No. of H-bondsa |
|---|---|---|---|
| PGN-I (B5) | Tyr366, Thr395, Asn397, Ser399, Tyr421, Asn423, Ser425, His426, Asn446, Ser448, Ser449, Asp467, Glu470, Thr497 | −4.29 | 6 |
| PGN-I (B6) | Ser259, Ser285, Tyr286, His312, Thr313, Arg342, Ser344, Tyr366 | −4.33 | 6 |
| PGN-DAP (B5) | Asp368, Leu369, Ser370, Gln371, Asn397, Ser399, Gln400, Tyr421, Asp423, Ser425, His426, Asn446, Ser448, Ser449, Asp467, Ser469, Glu470, Thr489 | −3.19 | 11 |
| PGN-DAP (B6) | Thr246, Glu254, Gly255, Lys258, Leu276, Thr277, Met279, Asp280, Gly281, Ser282, Ser283, Leu284, Ser304, Tyr305, Thr306, His307, Tyr308, Glu309 | −3.38 | 7 |
| LTA sites | Glu323, Phe324, Phe325, Glu326, Met330, Met331, Phe335, Thr349, Val350, Phe351, Val352, Ile353, Pro354, Pro355, Ile356, Leu360, Asn372, Leu373, Leu374, Pro381 | −1.92 | 1 |
| Zymosan | Leu473, Thr474, Val475, Phe476, Asn477, Thr495, Leu496, Pro497, His498, Gly499, Glu500, Leu501, Ser520, Ser521, Asp522, Arg525 | −7.55 | 13 |
aHydrogen bonds.
(b) Docking analysis of TLR2-ECD with PGN, LTA, and zymosan by FlexX 2.1
| Ligands | Interacting residues | Binding energy kcal/mol | No. of H-Bondsa |
|---|---|---|---|
| PGN-I | Asn397, Ser399, Gln400, Asn401, His426, Ser428, Lys451, Glu470 | −18.85 | 18 |
| PGN-II | Ser428, Phe429, Val430, Ser448, Lys451, Arg453, Lys454, Asp472, Ser469, Gln470 | −12.80 | 14 |
| PGN-DAP | Gln400, Asn401, His426, Ser428, Ser449, Lys451 | −15.47 | 15 |
| LTA | Asn318, Leu319, Asp320, Ile321, Phe324, Asn347, Gly348, Thr349, Val350, Gln371 | −6.92 | 13 |
| Zymosan | Arg492, Leu493, Met494, Leu496, Arg516, Met517, Ser520, Asp522 | −13.81 | 10 |
aHydrogen bonds.
(c) Docking analysis of TLR2-ECD with PGN, LTA, and zymosan by GOLD 4.1
| Ligands | Interacting residues | GOLD fitness score | No. of H-Bondsa |
|---|---|---|---|
| PGN-I (B5) | Ile394, Asn397, Ser399, Gln400, Tyr421, Asp423, Ser425, His426, Asn446, Ser448, Ser449, Asp467, Ser469, Glu470, Thr489, Gly490, Glu511, Arg512 | 42.38 | 17 |
| PGN-II (B5) | Tyr366, Asp368, Ser370, Gln371, Asn397, Ser399, Gln400, Tyr421, Ser425, Asn446, Ser448, Val465, Asp467, Ser469, Glu470, Thr489, Gly490, Arg512 | 44.01 | 20 |
| PGN-DAP (B5) | Asn446, Ser448, Ser449, Asp467, Ser469, Glu470, Ile487, Thr489, Gly490, Gln511, Arg512 | 40.55 | 13 |
| PGN-II (B6) | Thr246, Glu247, Pro248, Phe249, Lys250, Thr252, Thr277, Asp280, Ser304, Tyr305, Thr306, His307, Tyr308, | 23.00 | 8 |
| LTA | Leu319, Asp320, Ile321, Phe324, Phe327, Met330, Met331, Phe335, Gly348, Thr349, Val350, Phe351, Glu380, Pro381 | 44.65 | 4 |
| Zymosan | Arg492, Leu493, Met494, Thr495, Leu496, Ala514, Leu515, Arg516, Met517, Phe518, Asn519, Ser520, Ser521, Asp522, Arg525 | 39.71 | 8 |
aHydrogen bonds.